Clinical Trials Browser

Recurrence × Nivolumab × Plasma cell × Clear all

NCT03023527 2018-05-23

Nivolumab Role in the Treatment of Patients With Refractory or Relapse Multiple Myeloma

Phase 1 Terminated

Multiple Myeloma, Recurrence